粘蛋白
结肠炎
硫酸化
生物
肠道菌群
生物化学
罗伊乳杆菌
炎症性肠病
微生物学
酶
乳酸菌
内科学
免疫学
疾病
医学
发酵
作者
Mengfan Li,Yiyun Ding,Jingge Wei,Yue Dong,Jingyi Wang,Xin Dai,Jing Yan,Feifei Chu,Kexin Zhang,Fanyi Meng,Jiahui Ma,Weilong Zhong,Bangmao Wang,Yunhuan Gao,Rongcun Yang,Xinjuan Liu,Lei Su,Hailong Cao
标识
DOI:10.1080/19490976.2024.2377576
摘要
The global incidence and prevalence of inflammatory bowel disease (IBD) are gradually increasing. A high-fat diet (HFD) is known to disrupt intestinal homeostasis and aggravate IBD, yet the underlying mechanisms remain largely undefined. Here, a positive correlation between dietary fat intake and disease severity in both IBD patients and murine colitis models is observed. A HFD induces a significant decrease in indole-3-acetic acid (IAA) and leads to intestinal barrier damage. Furthermore, IAA supplementation enhances intestinal mucin sulfation and effectively alleviates colitis. Mechanistically, IAA upregulates key molecules involved in mucin sulfation, including 3'-phosphoadenosine 5'-phosphosulfate synthase 2 (Papss2) and solute carrier family 35 member B3 (Slc35b3), the synthesis enzyme and the transferase of 3'-phosphoadenosine-5'-phosphosulfate (PAPS), via the aryl hydrocarbon receptor (AHR). More importantly, AHR can directly bind to the transcription start site of Papss2. Oral administration of Lactobacillus reuteri, which can produce IAA, contributes to protecting against colitis and promoting mucin sulfation, while the modified L. reuteri strain lacking the iaaM gene (LactobacillusΔiaaM) and the ability to produce IAA fail to exhibit such effects. Overall, IAA enhances intestinal mucin sulfation through the AHR-Papss2-Slc35b3 pathway, contributing to the protection of intestinal homfeostasis.
科研通智能强力驱动
Strongly Powered by AbleSci AI